MEN2
Multiple endocrine neoplasia type 2 (MEN2) is a medical condition characterized by the occurrence of tumors in multiple endocrine glands. It is a rare condition, affecting approximately 1 in 30,000 individuals. MEN2 is further classified into three subtypes: MEN2A, MEN2B, and familial medullary thyroid carcinoma (FMTC).
Classification[edit | edit source]
MEN2 is classified into three subtypes based on the presence of specific tumors and other features:
- MEN2A is the most common subtype, accounting for about 70-80% of all MEN2 cases. It is characterized by the presence of medullary thyroid carcinoma (MTC), pheochromocytoma, and parathyroid hyperplasia or adenomas.
- MEN2B is a more aggressive subtype, accounting for about 5% of all MEN2 cases. It is characterized by MTC, pheochromocytoma, mucosal neuromas, and a distinctive physical appearance.
- Familial medullary thyroid carcinoma (FMTC) is characterized by the presence of MTC alone. It accounts for about 15-20% of all MEN2 cases.
Signs and symptoms[edit | edit source]
The signs and symptoms of MEN2 vary depending on the subtype and the specific tumors present. Common symptoms include:
- A lump in the neck due to MTC
- High blood pressure, sweating, and rapid heart rate due to pheochromocytoma
- Bone pain and fractures, kidney stones, or constipation due to hyperparathyroidism
Genetics[edit | edit source]
MEN2 is caused by mutations in the RET gene. This gene provides instructions for making a protein that is involved in signaling within cells. Mutations in the RET gene lead to the production of a protein that is constantly turned on, leading to uncontrolled cell growth and the formation of tumors.
Diagnosis[edit | edit source]
The diagnosis of MEN2 is based on clinical findings, family history, and genetic testing. Genetic testing can identify mutations in the RET gene that cause MEN2.
Treatment[edit | edit source]
The treatment of MEN2 depends on the specific tumors present. Surgery is the main treatment for MTC and pheochromocytoma. Medications may be used to manage symptoms of pheochromocytoma and hyperparathyroidism.
See also[edit | edit source]
| MEN2 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
